---
title: "HEALTHLYNKED CORP (HLYKD.US) — Financial Reports"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HLYKD.US/norm.md"
symbol: "HLYKD.US"
name: "HEALTHLYNKED CORP"
parent: "https://longbridge.com/en/quote/HLYKD.US.md"
datetime: "2026-03-16T05:14:47.787Z"
locales:
  - [en](https://longbridge.com/en/quote/HLYKD.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HLYKD.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HLYKD.US/norm.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/HLYKD.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/HLYKD.US/norm.md)


# HEALTHLYNKED CORP (HLYKD.US) — Financial Reports

## Income Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.2486 | -0.3727 | -0.4364 | -1.00 | -1.00 |
| ROE | 63.05% | 115.61% | 194.21% | 668.01% | 5908.17% |
| Revenue | 592360.00 | 774208.00 | 618927.00 | 590124.00 | 795078.00 |
| Net income | -701038.00 | -1.05M | -1.23M | -1.97M | -1.54M |

## Balance Sheet (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 1.85M | 2.06M | 2.22M | 2.76M | 3.86M |
| Leverage | -0.3890 | -0.4972 | -0.7104 | -1.43 | -9.09 |
| BVPS | -1.69 | -1.47 | -1.11 | -0.6865 | -0.1516 |
| Turnover | 0.9024 | 0.9342 | 0.9252 | 0.7862 | 0.8659 |

## Cash Flow Statement (USD)

| Indicator | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -417536.00 | -432553.00 | -743602.00 | -1.04M | -858694.00 |
| Investing CF | - | - | 425000.00 | 0.0000 | 0.0000 |
| Financing CF | 415467.00 | 378582.00 | 379885.00 | 879229.00 | 1.01M |
| Free CF | -412118.00 | -172507.00 | -96547.00 | -552881.00 | -327146.00 |